top of page
Developing safe, convenient, disease-modifying treatments for food allergies.
Aravax is a clinical-stage biotechnology company developing safe, convenient and disease-modifying treatments for peanut and other food allergies.
About Aravax
Aravax is a clinical-stage biotechnology company developing safe, convenient and disease-modifying treatments for food allergies.
​
Aravax uses proprietary platform technology to precisely reset the immune system to tolerate allergens, without provoking severe reactions during treatment
Clinical Trials
Phase 1 clinical trials of Aravax's lead product for peanut allergy, PVX108, have been successfully completed.
​
Phase 2 trials of PVX108 have commenced in peanut allergic adolescents and children and are fully recruited at clinics in Australia and the United States.
bottom of page